FarmaMondo SA announces it has established operations through its Global Access business unit into several south EU markets to allow direct to hospital supply of unlicensed medicines. The South European markets (Portugal, Spain, Italy and Greece) present a unique business and regulatory environment in the context of unlicensed medicines and require certain localized capabilities to efficiently support HCPs to access unlicensed medicines.
About FarmaMondo
FarmaMondo is a Swiss-based pharmaceutical company with a focus on providing paid access to unlicensed medicines. Our global footprint includes commercial operations in more than 70 markets, headquartered from Switzerland with regional hubs in Europe, Asia and Latin America.
